{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:10:20Z","timestamp":1790435420350,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      The renin-angiotensin system (RAS) plays a major role in liver fibrosis. Recently, a homolog of angiotensin-converting-enzyme 1 (ACE1), termed ACE2, has been identified that appears to be a negative regulator of the RAS by degrading Ang II to Ang\n                      <jats:sub>1-7<\/jats:sub>\n                      . The aim of this study was to characterize the long-term effects of gene deletion of ACE2 in the liver, to define the role of ACE2 in acute and chronic liver disease, and to characterize the role of Ang\n                      <jats:sub>1-7<\/jats:sub>\n                      in hepatic stellate cell (HSC) activation.\n                      <jats:italic toggle=\"yes\">Ace2<\/jats:italic>\n                      knockout (KO) mice and wild-type (wt) littermates underwent different models of acute and chronic liver injury. Liver pathology was analyzed by histology, immunohistochemistry, alpha smooth muscle actin (\u03b1-SMA) immunoblotting, and quantitative polymerase chain reaction (qPCR). Murine HSCs were isolated by collagenase-pronase-perfusion, and density gradient centrifugation. One-year-old\n                      <jats:italic toggle=\"yes\">ace2<\/jats:italic>\n                      KO mice spontaneously developed an inflammatory cell infiltration and mild hepatic fibrosis that was prevented by treatment with irbesartan.\n                      <jats:italic toggle=\"yes\">Ace2<\/jats:italic>\n                      KO mice showed increased liver fibrosis following bile duct ligation for 21 days or chronic carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) treatment. In contrast,\n                      <jats:italic toggle=\"yes\">ace2<\/jats:italic>\n                      KO mice subjected to acute liver injury models did not differ from wt littermates. Treatment with recombinant ACE2 attenuated experimental fibrosis in the course of cholestatic and toxic liver injury. HSCs express the Ang\n                      <jats:sub>1-7<\/jats:sub>\n                      receptor Mas and Ang\n                      <jats:sub>1-7<\/jats:sub>\n                      inhibited Ang II-induced phosphorylation of extracellular signal-regulated kinase (ERK)-1\/2 in cultured HSCs.\n                      <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>\n                      : ACE2 is a key negative regulator of the RAS and functions to limit fibrosis through the degradation of Ang II and the formation of Ang\n                      <jats:sub>1-7<\/jats:sub>\n                      . Whereas loss of ACE2 activity worsens liver fibrosis in chronic liver injury models, administration of recombinant ACE2 shows therapeutic potential. (Hepatology 2009.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.23104","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T08:05:38Z","timestamp":1243497938000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":121,"title":["Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #"],"prefix":"10.1097","volume":"50","author":[{"given":"Christoph H.","family":"\u00d6sterreicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Taura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"De Minicis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekihiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melitta","family":"Penz-\u00d6sterreicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef M.","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20241201","first-page":"147","article-title":"The reninangiotensin system.","volume":"28","author":"Inagami","year":"1994","journal-title":"Essays Biochem"},{"key":"R2-33-20241201","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensinconverting enzymerelated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 19.","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"R3-33-20241201","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase.","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"R4-33-20241201","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensinconverting enzyme 2 is an essential regulator of heart function.","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"R5-33-20241201","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensinconverting enzyme2 leads to the late development of angiotensin IIdependent glomerulosclerosis.","volume":"168","author":"Oudit","year":"2006","journal-title":"Am J Pathol"},{"key":"R7-33-20241201","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.","volume":"54","author":"Paizis","year":"2005","journal-title":"Gut"},{"key":"R8-33-20241201","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensinconverting enzyme 2 protects from severe acute lung failure.","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"R9-33-20241201","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensinconverting enzyme2 (Ace2) accelerates diabetic kidney injury.","volume":"171","author":"Wong","year":"2007","journal-title":"Am J Pathol"},{"key":"R10-33-20241201","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin IIinduced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"R11-33-20241201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2362.1983.tb00100.x","article-title":"Sympathetic nervous activity, reninangiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.","volume":"13","author":"Arroyo","year":"1983","journal-title":"Eur J Clin Invest"},{"key":"R12-33-20241201","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Upregulation of components of the reninangiotensin system in the bile ductligated rat liver.","volume":"123","author":"Paizis","year":"2002","journal-title":"Gastroenterology"},{"key":"R13-33-20241201","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the reninangiotensin system and synthesize angiotensin II.","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"R14-33-20241201","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.","volume":"112","author":"Bataller","year":"2003","journal-title":"J Clin Invest"},{"key":"R15-33-20241201","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R16-33-20241201","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensinconverting enzyme inhibition attenuates the progression of rat hepatic fibrosis.","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"key":"R17-33-20241201","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1386-6346(01)00102-4","article-title":"Antifibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachlorideinduced hepatic fibrosis in rats.","volume":"21","author":"Ohishi","year":"2001","journal-title":"Hepatol Res"},{"key":"R18-33-20241201","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(01)00146-5","article-title":"Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.","volume":"35","author":"Paizis","year":"2001","journal-title":"J Hepatol"},{"key":"R19-33-20241201","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","article-title":"AngiotensinII type 1 receptor interaction is a major regulator for liver fibrosis development in rats.","volume":"34","author":"Yoshiji","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R20-33-20241201","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3748\/wjg.v6.i6.824","article-title":"The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl(4).","volume":"6","author":"Wei","year":"2000","journal-title":"World J Gastroenterol"},{"key":"R21-33-20241201","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3748\/wjg.v6.i6.824","article-title":"Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).","volume":"6","author":"Wei","year":"2000","journal-title":"World J Gastroenterol"},{"key":"R22-33-20241201","first-page":"159","article-title":"Antifibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1R blocker on the hepatic fibrosis.","volume":"55","author":"Tuncer","year":"2003","journal-title":"Exp Toxicol Pathol"},{"key":"R23-33-20241201","first-page":"1499","article-title":"Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.","volume":"49","author":"Ramalho","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"R24-33-20241201","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis.","volume":"45","author":"Hirose","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R25-33-20241201","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGFbeta signaling and hepatic fibrosis.","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"R26-33-20241201","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","article-title":"Gene expression profiles during hepatic stellate cell activation in culture and in vivo.","volume":"132","author":"De Minicis","year":"2007","journal-title":"Gastroenterology"},{"key":"R27-33-20241201","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2008.07.065","article-title":"Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.","volume":"135","author":"Taura","year":"2008","journal-title":"Gastroenterology"},{"key":"R28-33-20241201","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.","volume":"285","author":"Bataller","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R29-33-20241201","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensinconverting enzyme 2 (ACE2) and angiotensin(17) levels in experimental biliary fibrosis.","volume":"47","author":"Herath","year":"2007","journal-title":"J Hepatol"},{"key":"R30-33-20241201","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin IIinduced cardiac remodeling by angiotensin(17).","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R31-33-20241201","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","article-title":"Angiotensin(17) attenuates the development of heart failure after myocardial infarction in rats.","volume":"105","author":"Loot","year":"2002","journal-title":"Circulation"},{"key":"R32-33-20241201","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.00317.2005","article-title":"Angiotensin(17) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.","volume":"289","author":"Iwata","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R33-33-20241201","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","article-title":"Angiotensin(17) inhibits growth of cardiac myocytes through activation of the Mas receptor.","volume":"289","author":"Tallant","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R34-33-20241201","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin(17) is a modulator of the human reninangiotensin system.","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"key":"R35-33-20241201","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.ki.5001509","article-title":"Angiotensin(17) inhibits angiotensin IIstimulated phosphorylation of MAP kinases in proximal tubular cells.","volume":"69","author":"Su","year":"2006","journal-title":"Kidney Int"},{"key":"R36-33-20241201","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","article-title":"The reninangiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin(17).","volume":"46","author":"Pereira","year":"2007","journal-title":"J Hepatol"},{"key":"R37-33-20241201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin IImediated oxidative stress and inflammation mediate the agedependent cardiomyopathy in ACE2 null mice.","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R38-33-20241201","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile ductligated rats.","volume":"41","author":"Bataller","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R39-33-20241201","doi-asserted-by":"crossref","first-page":"R745","DOI":"10.1016\/S0960-9822(02)01255-1","article-title":"Just the beginning: novel functions for angiotensinconverting enzymes.","volume":"12","author":"Eriksson","year":"2002","journal-title":"Curr Biol"},{"key":"R40-33-20241201","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.4049\/jimmunol.172.4.2542","article-title":"Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury.","volume":"172","author":"Souza","year":"2004","journal-title":"J Immunol"},{"key":"R41-33-20241201","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1096\/fj.05-5243fje","article-title":"TNFalpha upregulates apelin expression in human and mouse adipose tissue.","volume":"20","author":"Daviaud","year":"2006","journal-title":"FASEB J"},{"key":"R42-33-20241201","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI4217","article-title":"Neurotensin is a proinflammatory neuropeptide in colonic inflammation.","volume":"103","author":"Castagliuolo","year":"1999","journal-title":"J Clin Invest"},{"key":"R43-33-20241201","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cellsig.2004.09.018","article-title":"Apelin signalling: a promising pathway from cloning to pharmacology.","volume":"17","author":"Masri","year":"2005","journal-title":"Cell Signal"},{"key":"R44-33-20241201","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1053\/j.gastro.2007.09.023","article-title":"Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.","volume":"133","author":"SanchoBru","year":"2007","journal-title":"Gastroenterology"},{"key":"R45-33-20241201","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.22467","article-title":"The hepatic apelin system: a new therapeutic target for liver disease.","volume":"48","author":"Principe","year":"2008","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23104","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:28:29Z","timestamp":1733041709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23104","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1168445.630629","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}